Cuba Plans to Produce 10 Mln Doses of Hemophilia Flu Vaccines Annually

Cuba plans to produce 10 mln doses of hemophilia flu vaccines annually

HAVANA, Dec. 8 (Xinhua) — Cuba is planning to produce at least 10 million doses a year of a vaccine containing synthetic antigens against influenza hemophilia B, the vaccine’s inventor said on Thursday.

Vicente Verez from the University of Havana’s Antigen Research Center made the announcement during the 18th International Chemistry Conference in Santiago de Cuba, 860 km southeast of Cuba’s capital Havana.

Verez said the vaccine is the first of its kind in the world to use synthetic antigens as a base. He said he had seen positive results among inoculated children.

He said the vaccine would soon be exported and become available in some other countries.

Verez said vaccines against hemophilia flu were first developed in several industrial countries and few in underdeveloped nations could afford them as the prices are usually very high.

The scientist also said Cuba is working on a new project that promises to cure haemophilia flu and five other diseases in one shot.